Literature DB >> 26832657

Clinical Models and Algorithms for the Prediction of Retinopathy of Prematurity: A Report by the American Academy of Ophthalmology.

Amy K Hutchinson1, Michele Melia2, Michael B Yang3, Deborah K VanderVeen4, Lorri B Wilson5, Scott R Lambert1.   

Abstract

OBJECTIVE: To assess the accuracy with which available retinopathy of prematurity (ROP) predictive models detect clinically significant ROP and to what extent and at what risk these models allow for the reduction of screening examinations for ROP.
METHODS: A literature search of the PubMed and Cochrane Library databases was conducted last on May 1, 2015, and yielded 305 citations. After screening the abstracts of all 305 citations and reviewing the full text of 30 potentially eligible articles, the panel members determined that 22 met the inclusion criteria. One article included 2 studies, for a total of 23 studies reviewed. The panel extracted information about study design, study population, the screening algorithm tested, interventions, outcomes, and study quality. The methodologist divided the studies into 2 categories-model development and model validation-and assigned a level of evidence rating to each study. One study was rated level I evidence, 3 studies were rated level II evidence, and 19 studies were rated level III evidence.
RESULTS: In some cohorts, some models would have allowed reductions in the number of infants screened for ROP without failing to identify infants requiring treatment. However, the small sample size and limited generalizability of the ROP predictive models included in this review preclude their widespread use to make all-or-none decisions about whether to screen individual infants for ROP. As an alternative, some studies proposed approaches to apply the models to reduce the number of examinations performed in low-risk infants.
CONCLUSIONS: Additional research is needed to optimize ROP predictive model development, validation, and application before such models can be used widely to reduce the burdensome number of ROP screening examinations.
Copyright © 2016 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 26832657     DOI: 10.1016/j.ophtha.2015.11.003

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  18 in total

Review 1.  Advances in understanding and management of retinopathy of prematurity.

Authors:  Mary Elizabeth Hartnett
Journal:  Surv Ophthalmol       Date:  2016-12-22       Impact factor: 6.048

Review 2.  Retinopathy of prematurity: a review of risk factors and their clinical significance.

Authors:  Sang Jin Kim; Alexander D Port; Ryan Swan; J Peter Campbell; R V Paul Chan; Michael F Chiang
Journal:  Surv Ophthalmol       Date:  2018-04-19       Impact factor: 6.048

3.  Association of inflammatory and angiogenic biomarkers in maternal plasma with retinopathy of prematurity in preterm infants.

Authors:  Jae Shin Song; Se Joon Woo; Kyo Hoon Park; Hunmin Kim; Kyong-No Lee; Yu Mi Kim
Journal:  Eye (Lond)       Date:  2022-09-15       Impact factor: 4.456

4.  Single-Examination Risk Prediction of Severe Retinopathy of Prematurity.

Authors:  Aaron S Coyner; Jimmy S Chen; Praveer Singh; Robert L Schelonka; Brian K Jordan; Cindy T McEvoy; Jamie E Anderson; R V Paul Chan; Kemal Sonmez; Deniz Erdogmus; Michael F Chiang; Jayashree Kalpathy-Cramer; J Peter Campbell
Journal:  Pediatrics       Date:  2021-12-01       Impact factor: 9.703

5.  Validation of the Colorado Retinopathy of Prematurity Screening Model.

Authors:  Emily A McCourt; Gui-Shuang Ying; Anne M Lynch; Alan G Palestine; Brandie D Wagner; Erica Wymore; Lauren A Tomlinson; Gil Binenbaum
Journal:  JAMA Ophthalmol       Date:  2018-04-01       Impact factor: 7.389

6.  A Tiered Approach to Retinopathy of Prematurity Screening (TARP) Using a Weight Gain Predictive Model and a Telemedicine System.

Authors:  Jaclyn Gurwin; Lauren A Tomlinson; Graham E Quinn; Gui-Shuang Ying; Agnieshka Baumritter; Gil Binenbaum
Journal:  JAMA Ophthalmol       Date:  2017-02-01       Impact factor: 7.389

7.  Development and validation of a new clinical decision support tool to optimize screening for retinopathy of prematurity.

Authors:  Aldina Pivodic; Helena Johansson; Lois E H Smith; Anna-Lena Hård; Chatarina Löfqvist; Bradley A Yoder; M Elizabeth Hartnett; Carolyn Wu; Marie-Christine Bründer; Wolf A Lagrèze; Andreas Stahl; Abbas Al-Hawasi; Eva Larsson; Pia Lundgren; Lotta Gränse; Birgitta Sunnqvist; Kristina Tornqvist; Agneta Wallin; Gerd Holmström; Kerstin Albertsson-Wikland; Staffan Nilsson; Ann Hellström
Journal:  Br J Ophthalmol       Date:  2021-05-12       Impact factor: 5.908

8.  Fundus Pigmentation in the Diagnosis and Treatment of Retinopathy of Prematurity.

Authors:  Kenneth C Fan; Sarah P Read; Nimesh A Patel; Elizabeth A Vanner; Hasenin Al-Khersan; Diana M Laura; Parastou Pakravan; Catherin I Negron; Audina M Berrocal
Journal:  Ophthalmology       Date:  2020-12-29       Impact factor: 14.277

Review 9.  Role of cytokines and treatment algorithms in retinopathy of prematurity.

Authors:  M Elizabeth Hartnett
Journal:  Curr Opin Ophthalmol       Date:  2017-05       Impact factor: 3.761

10.  Validation of the DIGIROP-birth model in a Chinese cohort.

Authors:  Sizhe Chen; Rong Wu; He Chen; Wenbei Ma; Shaolin Du; Chao Li; Xiaohe Lu; Songfu Feng
Journal:  BMC Ophthalmol       Date:  2021-05-27       Impact factor: 2.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.